Autonomix Medical, Inc. (AMIX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$7.00M
As of 2026-03-31
$3.46M
As of 2026-06-30
+100.8%
3-year compound annual growth
$9.14M2023-03-31: $865.0K2024-03-31: $8.61M2025-03-31: $9.14M2026-03-31: $7.00M$7.00M
2023-03-31 Cash & Equivalents (USD) 2026-03-31
Period endedCash & EquivalentsChange YoYSource filing
2026-03-31$7.00M-23.3%2026-05-27, Balance as of period end
2025-03-31$9.14M+6.1%2026-05-27, Balance as of period end
2024-03-31$8.61M+895.1%2025-05-29, Balance as of period end
2023-03-31$865.0Kn/a2024-05-31, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Autonomix Medical, Inc. (AMIX)2026-03-31$7.00M-23.3%
Baxter International Inc (BAX)2025-12-31$1.97B+11.5%
Becton Dickinson & Co (BDX)2025-09-30$641.00M-62.7%
Teleflex Inc (TFX)2025-12-31$378.56M+52.7%
West Pharmaceutical Services Inc (WST)2025-12-31$791.30M+63.3%
Stryker Corp (SYK)2025-12-31$4.01B+9.8%
Haemonetics Corp (HAE)2026-03-28$245.44M-20.0%
KORU Medical Systems, Inc. (KRMD)2025-12-31$8.87M-7.4%
Utah Medical Products Inc (UTMD)2025-12-31$85.76M+3.4%

Compare AMIX, BAX, BDX, TFX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗